4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-26-001976
Director sold 24,520 shares at an average $522.39 ($12,808,957)
- Director acquired 24,520 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FRIEDMAN PAUL A Director | 2026-01-09 | Option exercise 10b5-1 | +24,520 | $15.80 | $387,416 | 211,684 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −1,480 | $511.98 | $757,727 | 210,204 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −1,094 | $513.11 | $561,340 | 209,110 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −1,345 | $514.68 | $692,246 | 207,765 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −1,996 | $515.81 | $1,029,561 | 205,769 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −766 | $516.84 | $395,896 | 205,003 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −2,450 | $517.86 | $1,268,755 | 202,553 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −1,363 | $518.68 | $706,966 | 201,190 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −846 | $519.88 | $439,822 | 200,344 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −681 | $521.03 | $354,823 | 199,663 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −840 | $521.98 | $438,461 | 198,823 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −970 | $523.00 | $507,307 | 197,853 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −1,199 | $524.10 | $628,394 | 196,654 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −2,432 | $525.05 | $1,276,916 | 194,222 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −1,066 | $526.00 | $560,717 | 193,156 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −1,560 | $526.97 | $822,071 | 191,596 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −575 | $528.18 | $303,702 | 191,021 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −691 | $529.17 | $365,653 | 190,330 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −166 | $529.76 | $87,941 | 190,164 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −280 | $530.69 | $148,592 | 189,884 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −80 | $532.50 | $42,600 | 189,804 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −332 | $534.16 | $177,342 | 189,472 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −148 | $535.29 | $79,223 | 189,324 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −473 | $536.02 | $253,538 | 188,851 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −487 | $536.88 | $261,459 | 188,364 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −80 | $537.85 | $43,028 | 188,284 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −480 | $539.23 | $258,831 | 187,804 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −600 | $540.36 | $324,215 | 187,204 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −40 | $545.79 | $21,832 | 187,164 | D |
| Derivatives | |||||||
| FRIEDMAN PAUL A Director | 2026-01-09 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −24,520 | 280 | D | ||
| Open-market sales · 24,520 sh · avg $522.39 · $12,808,957 | |||||||
Loading xslF345X05/wk-form4_1768340585.xml…